{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:56:18Z","timestamp":1792511778985,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872895"],"award-info":[{"award-number":["81872895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["RO-MY201712"],"award-info":[{"award-number":["RO-MY201712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18ZR1403900"],"award-info":[{"award-number":["18ZR1403900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.canlet.2021.10.034","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:12:17Z","timestamp":1635912737000},"page":"84-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":215,"special_numbering":"C","title":["Wnt signaling pathway in cancer immunotherapy"],"prefix":"10.1016","volume":"525","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-4600","authenticated-orcid":false,"given":"Di","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.10.034_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fimmu.2016.00460","article-title":"Modulation of inflammatory responses by wnt\/beta-catenin signaling in dendritic cells: a novel immunotherapy target for autoimmunity and cancer","volume":"7","author":"Suryawanshi","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2021.10.034_bib3","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1073\/pnas.1414167112","article-title":"beta-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10","volume":"112","author":"Fu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.10.034_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.10.034_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib6","volume":"vol. 34","author":"Luke","year":"2016"},{"key":"10.1016\/j.canlet.2021.10.034_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tips.2018.03.008","article-title":"Targeting wnt\/beta-catenin signaling for cancer immunotherapy","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2021.10.034_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1052932","article-title":"Tumors induce immune tolerance through activation of beta-catenin\/TCF4 signaling in dendritic cells: a novel therapeutic target for cancer immunotherapy","volume":"4","author":"Suryawanshi","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2021.10.034_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","article-title":"WNT signaling in cancer immunosurveillance","volume":"29","author":"Galluzzi","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2021.10.034_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization","volume":"48","author":"Zhao","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/0008-5472.CAN-14-2377","article-title":"beta-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells","volume":"75","author":"Hong","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2021.10.034_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cellimm.2016.09.006","article-title":"Interactions between canonical Wnt signaling pathway and MAPK pathway regulate differentiation, maturation and function of dendritic cells","volume":"310","author":"Xu","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.1102297","article-title":"Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt\/Ca2+\/NFAT\/NF-kappaB-B cell lymphoma 6 signaling","volume":"188","author":"Kim","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nn1374","article-title":"Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development","volume":"8","author":"Rosso","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2021.10.034_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ni.3313","article-title":"Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction","volume":"17","author":"Zhao","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.1401238","article-title":"A critical role for the regulated wnt-myc pathway in naive T cell survival","volume":"194","author":"Wong","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2326-6066.CIR-14-0167","article-title":"Melanoma-derived Wnt5a promotes local dendritic-cell expression of Ido and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy","volume":"3","author":"Holtzhausen","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2021.10.034_bib24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib25","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/s41388-019-0700-2","article-title":"WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer","volume":"38","author":"Castagnoli","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.10.034_bib26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1158\/2326-6066.CIR-17-0712","article-title":"Wnt3a\/beta-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers","volume":"6","author":"Schinzari","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2021.10.034_bib27","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.4049\/jimmunol.1400465","article-title":"Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity","volume":"193","author":"Boudousquie","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib28","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.1303417","article-title":"T Cell factor 1 represses CD8+ effector T cell formation and function","volume":"193","author":"Tiemessen","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15413-7","article-title":"TNIK signaling imprints CD8(+) T cell memory formation early after priming","volume":"11","author":"Jaeger-Ruckstuhl","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.10.034_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6235614","article-title":"Blockade of wnt\/beta-catenin pathway aggravated silica-induced lung inflammation through Tregs regulation on Th immune responses","volume":"2016","author":"Dai","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.canlet.2021.10.034_bib32","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1042\/CS20171256","article-title":"Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction","volume":"131","author":"Yang","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.canlet.2021.10.034_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/jimmunol\/198.3.986","article-title":"Pillars article: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"198","author":"Fontenot","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib34","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood-2012-09-456988","article-title":"Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg","volume":"122","author":"Baur","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2021.10.034_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01741","article-title":"Regulatory T cells promote overexpression of Lgr5 on gastric cancer cells via TGF-beta1 and confer poor prognosis in gastric cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.20182010","article-title":"Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells","volume":"216","author":"Xing","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization","volume":"48","author":"Zhao","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib38","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.4049\/jimmunol.1402691","article-title":"Canonical wnt signaling in dendritic cells regulates Th1\/Th17 responses and suppresses autoimmune neuroinflammation","volume":"194","author":"Suryawanshi","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau5240","article-title":"Pharmacological inhibition of beta-catenin\/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells","volume":"5","author":"Feng","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.canlet.2021.10.034_bib40","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1038\/s41388-019-0852-0","article-title":"Alterations in Wnt- and\/or STAT3 signaling pathways and the immune microenvironment during metastatic progression","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.10.034_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib43","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.4049\/jimmunol.1700247","article-title":"Wnt\/beta-Catenin signaling induces integrin alpha4beta1 in T cells and promotes a progressive neuroinflammatory disease in mice","volume":"199","author":"Sorcini","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib44","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.18632\/oncotarget.14834","article-title":"Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.10.034_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007607","article-title":"beta-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells","volume":"6","author":"Keerthivasan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2020.03.013","article-title":"Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity","volume":"52","author":"DiToro","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2021.10.034_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ygyno.2020.03.010","article-title":"Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer","volume":"157","author":"Betella","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm.4496","article-title":"DKK2 imparts tumor immunity evasion through beta-catenin-independent suppression of cytotoxic immune-cell activation","volume":"24","author":"Xiao","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41420-019-0204-4","article-title":"Neutralizing monoclonal antibody against Dickkopf2 impairs lung cancer progression via activating NK cells","volume":"5","author":"Shen","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2021.10.034_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226928","article-title":"Surrogate R-spondins for tissue-specific potentiation of wnt signaling","volume":"15","author":"Luca","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2021.10.034_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20150950","article-title":"Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer","volume":"213","author":"D'Amico","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib54","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2010-04-281394","article-title":"Natural killer-cell differentiation by myeloid progenitors","volume":"117","author":"Grzywacz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2021.10.034_bib55","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.1100835","article-title":"Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling","volume":"187","author":"Cichocki","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-019-00503-3","article-title":"Wnt antagonists in hematopoietic and immune cell fate: implications for osteoporosis therapies","volume":"17","author":"Chicana","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.canlet.2021.10.034_bib57","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1634\/stemcells.2007-0102","article-title":"The interaction of the Wnt and Notch pathways modulates natural killer versus T cell differentiation","volume":"25","author":"Aoyama","year":"2007","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2021.10.034_bib58","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib59","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2021.10.034_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib61","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/molehr\/gaw026","article-title":"Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-beta\/beta-catenin pathway","volume":"22","author":"Kang","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.canlet.2021.10.034_bib63","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1158\/0008-5472.CAN-08-3806","article-title":"Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow","volume":"69","author":"Poh","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib64","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-15-0898","article-title":"The CUL4B\/AKT\/beta-Catenin Axis restricts the accumulation of myeloid-derived suppressor cells to prohibit the establishment of a tumor-permissive microenvironment","volume":"75","author":"Qian","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib65","first-page":"1431","article-title":"Hdc-expressing myeloid-derived suppressor cells promote basal-like transition and metastasis of breast cancer","volume":"13","author":"Chen","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2021.10.034_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.canlet.2021.10.034_bib67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14712598.2017.1271874","article-title":"Targeting cancer stem cells with natural killer cell immunotherapy","volume":"17","author":"Luna","year":"2017","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.canlet.2021.10.034_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2018.01.011","article-title":"Therapeutic cancer vaccines: from initial findings to prospects","volume":"196","author":"Song","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.canlet.2021.10.034_bib69","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-10-0356","article-title":"Wnt\/beta-catenin signaling in T-cell immunity and cancer immunotherapy","volume":"16","author":"Gattinoni","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib70","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib71","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.1102282","article-title":"Immune suppression and resistance mediated by constitutive activation of Wnt\/\u03b2-catenin signaling in human melanoma cells","volume":"189","author":"Yaguchi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib72","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2021.10.034_bib73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2013.07.019","article-title":"Canonical Wnt signaling negatively modulates regulatory T cell function","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib78","article-title":"CTLA-4 and PD-1 pathway blockade: combinations in the clinic","volume":"4","author":"Callahan","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.canlet.2021.10.034_bib79","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2016.01.001","article-title":"The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer","volume":"130","author":"Ward","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nm0216-122","article-title":"Mutations as munitions: neoantigen vaccines get a closer look as cancer treatment","volume":"22","author":"Katsnelson","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib82","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib83","doi-asserted-by":"crossref","first-page":"B03","DOI":"10.1158\/2326-6074.TUMIMM17-B03","article-title":"Abstract B03: RNAi-mediated \u03b2-catenin inhibition sensitizes noninflamed tumors to immune checkpoint blockade","volume":"6","author":"Ganesh","year":"2018","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.canlet.2021.10.034_bib84","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2021.10.034_bib85","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.1102282","article-title":"Immune suppression and resistance mediated by constitutive activation of Wnt\/beta-catenin signaling in human melanoma cells","volume":"189","author":"Yaguchi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib86","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.ymthe.2018.09.005","article-title":"RNAi-mediated beta-catenin inhibition promotes T cell infiltration and antitumor activity in combination with immune checkpoint blockade","volume":"26","author":"Ganesh","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2021.10.034_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of Co-receptor PD-1 to enhance CD8(+) cytolytic T cell responses","volume":"44","author":"Taylor","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2021.10.034_bib88","series-title":"Effectiveness and Safety of Chemotherapy with Cytokine-Induced Killer Cells in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials","author":"Xiao","year":"2018"},{"key":"10.1016\/j.canlet.2021.10.034_bib89","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib90","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.e15038","article-title":"Effect of RNAi-based \u03b2-catenin inhibition on immunosuppressive Wnt-activated tumors in combination with IDOi\/PD-1 immunotherapy","volume":"36","author":"Ganesh","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib91","first-page":"46","article-title":"PAK4 inhibition improves PD-1 blockade immunotherapy","volume":"1","author":"Abril-Rodriguez","year":"2019","journal-title":"Nat. Can."},{"key":"10.1016\/j.canlet.2021.10.034_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42003-020-0916-2","article-title":"Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models","volume":"3","author":"Waaler","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.canlet.2021.10.034_bib93","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.TPS3623","article-title":"Multicenter phase I\/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503","volume":"35","author":"Kuboki","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41556-020-0507-y","article-title":"Overcoming Wnt-beta-catenin dependent anticancer therapy resistance in leukaemia stem cells","volume":"22","author":"Perry","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2021.10.034_bib95","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1038\/s41388-020-1267-7","article-title":"Temporal activation of WNT\/beta-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth","volume":"39","author":"Uka","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.10.034_bib96","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2015.06.004","article-title":"Engineering CAR-T cells: design concepts","volume":"36","author":"Srivastava","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cr.2016.155","article-title":"Immune targets and neoantigens for cancer immunotherapy and precision medicine","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib98","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2217\/fon-2017-0459","article-title":"Advances in immunotherapy for acute myeloid leukemia","volume":"14","author":"Przespolewski","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib99","series-title":"Immunotherapy in Acute Myeloid Leukemia and Myelodysplastic Syndromes: the Dawn of a New Era?","author":"Liu","year":"2018"},{"key":"10.1016\/j.canlet.2021.10.034_bib100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrclinonc.2016.36","article-title":"Driving CAR T-cells forward","volume":"13","author":"Jackson","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.10.034_bib101","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.10.034_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-018-0759-3","article-title":"Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2021.10.034_bib103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.10.034_bib104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.10.034_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02293","article-title":"WNT\/\u03b2-Catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib107","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-17-3973","article-title":"In vitro priming of adoptively transferred T cells with a RORgamma agonist confers durable memory and stemness in vivo","volume":"78","author":"Hu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15338","article-title":"Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy","volume":"8","author":"Kondo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.10.034_bib109","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","author":"Keskin","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.10.034_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00467","article-title":"Therapeutic cancer vaccine and combinations with antiangiogenic therapies and immune checkpoint blockade","volume":"10","author":"Mougel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-008-9095-3","article-title":"Wnt\/Frizzled signaling in angiogenesis","volume":"11","author":"Zerlin","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.canlet.2021.10.034_bib112","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7150\/thno.30056","article-title":"Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2021.10.034_bib113","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2019-3645","article-title":"Abstract 3645: cooperation between canonical Wnt and TGF-beta pathways promotes sarcoma angiogenesis","volume":"79","author":"Hawkins","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.034_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2011.455","article-title":"Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo","volume":"31","author":"Ramachandran","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.10.034_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.356","article-title":"miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt\/\u03b2-catenin signaling through targeting BCL9","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2021.10.034_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8070062","article-title":"Modulating dickkopf-1: a strategy to monitor or treat cancer?","volume":"8","author":"Mazon","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.10.034_bib117","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1073\/pnas.1508113112","article-title":"Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia","volume":"112","author":"Koo","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.10.034_bib118","series-title":"An Autologous Dendritic Cell Vaccine Polarizes a Th-1 Response Which Is Tumoricidal to Patient-Derived Breast Cancer Cells","author":"Tomasicchio","year":"2018"},{"key":"10.1016\/j.canlet.2021.10.034_bib119","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","author":"Hilf","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.10.034_bib120","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ymthe.2018.06.008","article-title":"Personalized cancer vaccine platform for clinically relevant oncolytic enveloped viruses","volume":"26","author":"Ylosmaki","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2021.10.034_bib121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jgm.2893","article-title":"Oncolytic vaccinia virus inhibits human hepatocellular carcinoma MHCC97-H cell proliferation via endoplasmic reticulum stress, autophagy and Wnt pathways","volume":"18","author":"Jia","year":"2016","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41389-018-0048-4","article-title":"CARF enrichment promotes epithelial-mesenchymal transition via Wnt\/beta-catenin signaling: its clinical relevance and potential as a therapeutic target","volume":"7","author":"Kalra","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2021.10.034_bib123","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbrc.2017.07.041","article-title":"A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models","volume":"491","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2021.10.034_bib124","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.trecan.2015.10.004","article-title":"Oncolytic viruses: exploiting cancer's deal with the devil","volume":"1","author":"Pikor","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2021.10.034_bib125","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1128\/AAC.00029-13","article-title":"Wnt modulating agents inhibit human cytomegalovirus replication","volume":"57","author":"Kapoor","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.canlet.2021.10.034_bib126","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/JVI.75.6.2857-2865.2001","article-title":"Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway","volume":"75","author":"Brunori","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.10.034_bib127","series-title":"Dietary Phytochemicals in Colorectal Cancer Prevention and Treatment: A Focus on the Molecular Mechanisms Involved","author":"Afrin","year":"2018"},{"key":"10.1016\/j.canlet.2021.10.034_bib128","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/acs.jafc.7b04975","article-title":"Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways","volume":"66","author":"Chen","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2021.10.034_bib129","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1073\/pnas.1000072107","article-title":"Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88","volume":"108","author":"Cheesman","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.10.034_bib130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/carcin\/20.8.1425","article-title":"Increased tight junctional permeability is associated with the development of colon cancer","volume":"20","author":"Soler","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2021.10.034_bib131","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PPO.0000000000000050","article-title":"Gut microbiome and colorectal adenomas","volume":"20","author":"Dulal","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.canlet.2021.10.034_bib132","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.canlet.2021.10.034_bib133","doi-asserted-by":"crossref","first-page":"G220","DOI":"10.1152\/ajpgi.00498.2003","article-title":"Bacterial activation of beta-catenin signaling in human epithelia","volume":"287","author":"Sun","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2021.10.034_bib134","doi-asserted-by":"crossref","first-page":"G129","DOI":"10.1152\/ajpgi.00515.2004","article-title":"Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells","volume":"289","author":"Sun","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2021.10.034_bib135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/labinvest.3700545","article-title":"beta-Catenin activity negatively regulates bacteria-induced inflammation","volume":"87","author":"Duan","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.canlet.2021.10.034_bib136","doi-asserted-by":"crossref","first-page":"24285","DOI":"10.1073\/pnas.1912129116","article-title":"Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures","volume":"116","author":"Sobhani","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.10.034_bib137","series-title":"Synbindin Deficiency Inhibits Colon Carcinogenesis by Attenuating Wnt Cascade and Balancing Gut Microbiome","author":"Ai","year":"2018"},{"key":"10.1016\/j.canlet.2021.10.034_bib138","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","article-title":"Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2021.10.034_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2018.07.002","article-title":"Mechanisms of action of vitamin D in colon cancer","volume":"185","author":"Ferrer-Mayorga","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.canlet.2021.10.034_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00879","article-title":"Oral hygiene might prevent cancer","volume":"4","author":"Cordero","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2021.10.034_bib141","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/eci.13.27","article-title":"Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer","volume":"9","author":"Moossavi","year":"2013","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib142","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0973-1482.113348","article-title":"Cancer patients with cardiac pacemakers needing radiation treatment: a systematic review","volume":"9","author":"Munshi","year":"2013","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.canlet.2021.10.034_bib143","first-page":"1","article-title":"Treatment of rectal cancer by transanal endoscopic microsurgery: review of the literature","volume":"68","author":"Lezoche","year":"2013","journal-title":"Minerva Chir."},{"key":"10.1016\/j.canlet.2021.10.034_bib144","first-page":"303","article-title":"Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance","volume":"19","author":"Swafford","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.canlet.2021.10.034_bib145","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2021.10.034_bib146","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028472","article-title":"Cytokines in cancer immunotherapy","volume":"10","author":"Waldmann","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.canlet.2021.10.034_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02772","article-title":"Mechanisms and functions of chemerin in cancer: potential roles in therapeutic intervention","volume":"9","author":"Shin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.10.034_bib148","article-title":"Promising immunotherapy: highlighting cytokine-induced killer cells","author":"Shirjang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.10.034_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01290","article-title":"Mechanisms of cancer resistance to immunotherapy","volume":"10","author":"Bai","year":"2020","journal-title":"Front Oncol"},{"issue":"21","key":"10.1016\/j.canlet.2021.10.034_bib150","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/1078-0432.CCR-13-0694","article-title":"Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature","volume":"19","author":"Herrera","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2021.10.034_bib151","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2353\/ajpath.2007.060661","article-title":"Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment","volume":"171","author":"Mueller","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.canlet.2021.10.034_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077366","article-title":"TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2021.10.034_bib153","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fonc.2015.00063","article-title":"Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer","volume":"5","author":"Tommelein","year":"2015","journal-title":"Front Oncol"},{"issue":"44","key":"10.1016\/j.canlet.2021.10.034_bib154","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1038\/sj.onc.1208013","article-title":"Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles","volume":"23","author":"Nakagawa","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2021.10.034_bib155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12307-010-0038-3","article-title":"The tumor microenvironment in colorectal carcinogenesis","volume":"3","author":"Peddareddigari","year":"2010","journal-title":"Cancer Microenvironment"},{"issue":"2","key":"10.1016\/j.canlet.2021.10.034_bib156","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/pmic.201200179","article-title":"Differential secretome analysis of cancer\u2010associated fibroblasts and bone marrow\u2010derived precursors to identify microenvironmental regulators of colon cancer progression","volume":"13","author":"De Boeck","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.canlet.2021.10.034_bib157","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","article-title":"Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer","volume":"23","author":"Unterleuthner","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.canlet.2021.10.034_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau5240","article-title":"Pharmacological inhibition of \u03b2-catenin\/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells","volume":"5","author":"Feng","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2021.10.034_bib159","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41388-021-01756-y","article-title":"BCL9\/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.10.034_bib160","doi-asserted-by":"crossref","first-page":"67674","DOI":"10.18632\/oncotarget.11874","article-title":"Biological functions of macrophage-derived Wnt5a, and its roles in human diseases","volume":"7","author":"Shao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.10.034_bib161","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI84658","article-title":"CKAP4 is a Dickkopf1 receptor and is involved in tumor progression","volume":"126","author":"Kimura","year":"2016","journal-title":"J. Clin. Invest."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521005504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521005504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:59:55Z","timestamp":1759593595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521005504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":157,"alternative-id":["S0304383521005504"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.10.034","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wnt signaling pathway in cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}